Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
SR Pharma plc is a European biopharmaceutical company, listed on AIM. The Company has two operating subsidiaries Atugen AG based in Berlin, Germany and Stanford Rook Ltd based in London, UK. Atugen is a leader in RNAi therapeutics based on its 8 years experience in functional gene silencing and delivery combined with its strong biology expertise. Atugen has developed novel, chemically modified proprietary siRNA molecules (“AtuRNAi”) and a proprietary delivery system (“AtuPLEX”) which both have several advantages over conventional siRNA molecules and their delivery systems. ( www.srpharma.com )
SR Pharma plc
Centre Point, 26Th Floor 103 New Oxford Street
London WC1A 1DD
United Kingdom
Tel: +44 20 7307 1620
Fax: +44 20 7307 1680